DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Leiter LA, Carr MC, Stewart M et al.
Efficacy and safety of the once-weekly GLP-1 receptor agonist albiglutide versus sitagliptin in patients with type 2 diabetes and renal impairment: a randomized phase III study.
Diabetes Care 2014;
37: 2723-2730
Access:
We do not assume any responsibility for the contents of the web pages of other providers.